Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
21SEP

Rivan raises £25m for Europe's biggest SNG plant

3 min read
16:52UTC

A Wiltshire startup pulled IQ Capital, Plural, and a European founder-angel trio onto its cap table to build synthetic gas at 15MW scale.

← Back to Nscale takes $103.4bn of contracts to NYSEJump to analysis ↓
TechnologyDeveloping
Key takeaway

Rivan's angel syndicate shows UK cleantech can scale outside state programmes if European operator capital backs it.

Rivan, founded by Harvey Hodd, raised £25m on 20 April 2026 to build Project Steadfast, a 15MW synthetic natural gas plant in Wiltshire. IQ Capital led with Plural; angel investors included Matt Clifford of Entrepreneur First, Thomas Wolf of Hugging Face, and Markus Villig of Bolt. Total raised now stands at $46m, and the company has a commercial offtake partnership with Wales & West Utilities.

Synthetic natural gas (SNG) is methane manufactured from captured CO2 and green hydrogen rather than extracted from a well. The output is molecularly identical to fossil gas, meaning it runs on existing pipeline infrastructure, boilers, and industrial burners without replacement capex; that substitutability is the commercial proposition. Project Steadfast's 15MW scale makes it Europe's largest SNG facility and the first to inject SNG directly into the UK gas grid.

Four backers, four distinct European pedigrees. IQ Capital is a Cambridge deep-tech VC; Plural is a European fund founded by the Skype and Wise operators. The three angels each founded a category-defining European company: Clifford's Entrepreneur First runs the continent's largest talent-first accelerator; Wolf co-founded the AI platform Hugging Face; Villig built Bolt into Europe's largest ride-hailing operator by vehicle count. A cleantech startup pulling that mix of operator angels onto a grid-injection project is a signal about where European founder capital is migrating, and it is not toward the same US-dominated climate funds that dominated the last boom.

The cleantech vertical sits outside the UK's main targeted state-capital corridors. SAIU targets AI , ProQure targets quantum , LSIMF targets life sciences, and there is no equivalent multi-billion programme specifically for synthetic fuels. Rivan demonstrates that UK cleantech can still assemble material capital through VC plus founder-angel syndication at single-digit-£10m ticket sizes, though the ceiling on that mechanism is £25m, not £250m.

Deep Analysis

In plain English

Synthetic natural gas (SNG) is made by converting hydrogen into a gas that works exactly like the natural gas already in UK homes and factories. Rivan is building Europe's biggest factory for this process in Wiltshire, and it will be the first time this kind of gas has been pumped directly into the UK gas grid. The advantage is that industries using gas-powered furnaces or boilers do not need to change their equipment; they just switch to a cleaner version of the fuel they already use. The investors include the founders of Hugging Face and Bolt, two very well-known European tech companies, which is unusual for what is essentially an energy infrastructure project.

Deep Analysis
Root Causes

Natural gas demand from industries that cannot electrify; glass furnaces, ceramics, food processing, steel reheating; is projected to persist at 30-40% of current UK industrial gas consumption through 2040 per National Grid ESO's Future Energy Scenarios (2025); SNG from green hydrogen is the only currently technically viable substitute that does not require those industries to refit their combustion equipment.

The UK's hydrogen strategy (2021) allocated £240m to hydrogen production but did not create a mandatory blending target for the gas grid, leaving SNG injection commercially marginal without a voluntary green premium; Rivan's angel syndicate; Clifford, Wolf, Villig; reflects the project's dependence on conviction capital rather than policy-backed debt.

What could happen next?
  • Consequence

    Project Steadfast will be the first commercial test of whether the UK gas grid's metering infrastructure can issue Renewable Gas Guarantees of Origin for SNG at MW scale; if Wales and West Utilities cannot certify the injection, the project's revenue model collapses to commodity gas pricing and Rivan will need a Contracts for Difference application to reach Series B.

  • Opportunity

    A successful 15MW SNG injection at Wiltshire gives Rivan a replicable template for sites near industrial gas clusters; Teesside, Humber, Grangemouth; where hard-to-abate manufacturing demand is concentrated and grid injection capacity already exists, unlocking a pipeline of 10-15 further sites without new grid infrastructure.

Sources:City AM
Mentions:Rivan →Plural →Matt Clifford →Thomas Wolf →Markus Villig →Entrepreneur First →Hugging Face →Bolt →Wales →Cambridge →ProQure →Project Steadfast →Harvey Hodd →Wiltshire →Sovereign AI Unit →Venture Capital Trusts →Life Sciences Innovative Manufacturing Fund →
First Reported In

Update #2 · Britain's innovation pipe leaks at both ends

City AM· 22 Apr 2026
Read original →
Causes and effects
This Event
Rivan raises £25m for Europe's biggest SNG plant
Rivan's syndicate pairs UK deep-tech VC with three European category-defining founders, a pattern that routes scale-up validation to UK cleantech without VCT dependency.
Led to
Nyobolt hits £1bn on Symbotic-led Series C
IQ Capital's participation in Nyobolt Series C continues its pattern of anchoring Cambridge deeptech spinout rounds alongside strategics, as it did in the Rivan raise (ID:2702).
Occurred 6 May 2026
Read story →
Mykor's £4m grows panels from mushrooms
Rivan's £25m cleantech raise in Wiltshire (ID:2702) showed regional, non-Golden-Triangle deeptech capital continues to flow outside AI; Mykor's £4m Bristol raise echoes that pattern.
Occurred 27 May 2026
Read story →
Different Perspectives
Nscale and Open Cosmos
Nscale and Open Cosmos
Nscale chose the New York Stock Exchange for its listing on 18 September, putting Britain's largest AI infrastructure bet to American public investors rather than British ones. Open Cosmos took the opposite route four days earlier, raising nine figures from an all-domestic syndicate on five years of profit, evidence that staying is possible when the balance sheet allows it.
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Committee chair Dame Chi Onwurah wrote to government on 7 September asking how Matt Clifford's conflict at ARIA arose and what safeguards protect its governance, and expects a detailed response. Her question has not yet been put to the Sovereign AI Unit, whose own chair sits at a venture capital firm while overseeing state AI equity.
The Entrepreneurs Network
The Entrepreneurs Network
The Entrepreneurs Network's founder survey found 65% say Britain is easy to start a business in but only 14% say it is easy to scale one, with 82% negative on tax and 74% finding investment hard to access. On this reading the constraint is regulation and tax, not the capital-vehicle design the state keeps adjusting.
New Economics Foundation
New Economics Foundation
The New Economics Foundation argues fiscal accounting rules, not political will, cap what Britain's state capital vehicles can do. Matching the KfW and Bpifrance benchmark of 1% of GDP would need the National Wealth Fund to deploy roughly GBP21bn a year by 2028-29, about four times its current capacity.
Competition and Markets Authority
Competition and Markets Authority
The CMA's 8 September report on public procurement asked whether Britain's roughly GBP400bn state-spending system is built to grow high-potential firms rather than simply widen SME participation. Its Recommendation 5 calls for a dedicated frontier-technology procurement framework, an official acknowledgement that today's design may serve the wrong target.
Highland Europe
Highland Europe
Highland Europe, the growth-equity firm behind a €1bn-plus fund, took €65m from the British Business Bank into its Technology Growth Fund VI on 30 July via British Patient Capital. For a Geneva-based growth investor, the Bank's cheque is routine cornerstone capital, unrelated to which Whitehall department currently claims to sponsor UKRI.